HUP0201336A3 - The use of nmda antagonist compounds for producing medicaments useful for prophylaxis of dyskinesias - Google Patents
The use of nmda antagonist compounds for producing medicaments useful for prophylaxis of dyskinesiasInfo
- Publication number
- HUP0201336A3 HUP0201336A3 HU0201336A HUP0201336A HUP0201336A3 HU P0201336 A3 HUP0201336 A3 HU P0201336A3 HU 0201336 A HU0201336 A HU 0201336A HU P0201336 A HUP0201336 A HU P0201336A HU P0201336 A3 HUP0201336 A3 HU P0201336A3
- Authority
- HU
- Hungary
- Prior art keywords
- dyskinesias
- prophylaxis
- antagonist compounds
- nmda antagonist
- medicaments useful
- Prior art date
Links
- 208000012661 Dyskinesia Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28587001P | 2001-04-23 | 2001-04-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0201336D0 HU0201336D0 (enExample) | 2002-06-29 |
| HUP0201336A2 HUP0201336A2 (hu) | 2004-04-28 |
| HUP0201336A3 true HUP0201336A3 (en) | 2004-07-28 |
Family
ID=23096048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201336A HUP0201336A3 (en) | 2001-04-23 | 2002-04-22 | The use of nmda antagonist compounds for producing medicaments useful for prophylaxis of dyskinesias |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030004187A1 (enExample) |
| EP (1) | EP1254661A1 (enExample) |
| JP (1) | JP2002332246A (enExample) |
| KR (1) | KR20020082151A (enExample) |
| CN (1) | CN1382442A (enExample) |
| AU (1) | AU3439602A (enExample) |
| CA (1) | CA2381630A1 (enExample) |
| HK (1) | HK1048071A1 (enExample) |
| HU (1) | HUP0201336A3 (enExample) |
| IL (1) | IL149148A0 (enExample) |
| PL (1) | PL353582A1 (enExample) |
| ZA (1) | ZA200203180B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7005432B2 (en) | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
| DE10338174A1 (de) | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| EP2150239A1 (en) * | 2007-04-24 | 2010-02-10 | Boehringer Ingelheim International GmbH | Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| DE102007047737A1 (de) * | 2007-10-05 | 2009-04-30 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
| US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
| US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| US10633336B2 (en) | 2014-12-19 | 2020-04-28 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 薬剤送達方法及びシステム |
| US10679516B2 (en) | 2015-03-12 | 2020-06-09 | Morningside Venture Investments Limited | Craving input and support system |
| KR101657420B1 (ko) * | 2015-08-31 | 2016-10-14 | 고려공업검사 주식회사 | 열교환기 튜브 검사용 홀더 |
| US11285306B2 (en) | 2017-01-06 | 2022-03-29 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| WO2020102695A1 (en) | 2018-11-16 | 2020-05-22 | Cti (Assignment For Benefit Of Creditors) Llc | Thermally regulated transdermal drug delivery system |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU760800B2 (en) * | 1997-10-24 | 2003-05-22 | Warner-Lambert Company | Method for treating disease-related or drug-induced dyskinesias |
| PE20000728A1 (es) * | 1998-06-26 | 2000-08-21 | Cocensys Inc | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda |
-
2002
- 2002-04-11 CA CA002381630A patent/CA2381630A1/en not_active Abandoned
- 2002-04-15 IL IL14914802A patent/IL149148A0/xx unknown
- 2002-04-17 EP EP02008620A patent/EP1254661A1/en not_active Withdrawn
- 2002-04-18 AU AU34396/02A patent/AU3439602A/en not_active Abandoned
- 2002-04-22 ZA ZA200203180A patent/ZA200203180B/xx unknown
- 2002-04-22 HU HU0201336A patent/HUP0201336A3/hu unknown
- 2002-04-22 KR KR1020020022046A patent/KR20020082151A/ko not_active Ceased
- 2002-04-23 PL PL02353582A patent/PL353582A1/xx not_active Application Discontinuation
- 2002-04-23 JP JP2002121217A patent/JP2002332246A/ja active Pending
- 2002-04-23 US US10/127,999 patent/US20030004187A1/en not_active Abandoned
- 2002-04-23 CN CN02116192A patent/CN1382442A/zh active Pending
-
2003
- 2003-01-14 HK HK03100309.3A patent/HK1048071A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2381630A1 (en) | 2002-10-23 |
| ZA200203180B (en) | 2003-10-22 |
| HK1048071A1 (zh) | 2003-03-21 |
| EP1254661A1 (en) | 2002-11-06 |
| PL353582A1 (en) | 2002-11-04 |
| HU0201336D0 (enExample) | 2002-06-29 |
| JP2002332246A (ja) | 2002-11-22 |
| US20030004187A1 (en) | 2003-01-02 |
| HUP0201336A2 (hu) | 2004-04-28 |
| IL149148A0 (en) | 2002-11-10 |
| CN1382442A (zh) | 2002-12-04 |
| KR20020082151A (ko) | 2002-10-30 |
| AU3439602A (en) | 2002-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL369006A1 (en) | Preparation for the prophylaxis of restenosis | |
| IL189657A (en) | Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives | |
| SI1390023T1 (sl) | Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana | |
| HUP0500851A3 (en) | Process for the preparation of rosuvastatin | |
| HUP0401642A3 (en) | Use of staurosporine derivatives for the preparation of pharmaceutical compositions | |
| HUP0201336A3 (en) | The use of nmda antagonist compounds for producing medicaments useful for prophylaxis of dyskinesias | |
| AU2002341241A1 (en) | Process for the preparation of fast dissolving dosage form | |
| HUP0401600A3 (en) | Process for the preparation of 14-hydroxymorphine derivatives | |
| IL143106A (en) | Process for the preparation of diphenylmethylthioacetamide | |
| PT1446107E (pt) | Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso | |
| IL165137A0 (en) | Process for the preparation of thioalkylamine derivatives | |
| HUP0401599A3 (en) | Extended release oral dosage form | |
| PL373627A1 (en) | Process for the preparation of melamine | |
| MY136695A (en) | Process for the preparation of alkylaryl compounds | |
| IL162770A (en) | Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives | |
| HUP0303025A3 (en) | Process for the preparation of arylethanoldiamines | |
| AU2002337601A1 (en) | Process for the preparation of simvastatin | |
| AU2002359034A1 (en) | Process for the preparation of simvastatin | |
| SG111997A1 (en) | Improved process for the preparation of polyalkylphenoxyaminoalkanes | |
| GB0209254D0 (en) | Preparation for the relief of disease | |
| IL164788A0 (en) | Process for the preparation of 3-isochromanone | |
| PL368905A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
| AU2002342940A8 (en) | New pharmaceutical compounds | |
| AU2002229479B2 (en) | Preparation for the prophylaxis of restenosis | |
| AU2002330285A1 (en) | Triclosan dosage form |